OPTIMIZERx Corp (OPRX)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $138.26M
Last updated: Nov 17, 2026 at 11:06 AM ET
OPTIMIZERx Corp (OPRX) Financials: Revenue, Profit and Cash Flow
OPTIMIZERx reported revenue of $109.43M for the fiscal year ended Dec 31, 2025, up 18.8% from the year before. That year, net income was $5.13M with a net margin of 4.7%, operating cash flow was $18.71M and free cash flow was $18.65M. The quarter ended Sep 30, 2026 had revenue of $21.61M and net income of $1.20M.
Revenue and Margins
The operating margin was 10.7% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $4.34M, a compound annual rate of 43.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $109.43M | +18.8% | 67.3% | 10.7% | 4.7% |
| Dec 2024 | $92.13M | +28.8% | 64.5% | -14.9% | -21.8% |
| Dec 2023 | $71.52M | +14.5% | 60.0% | -36.9% | -24.6% |
| Dec 2022 | $62.45M | +1.9% | 62.4% | -19.7% | -18.3% |
| Dec 2021 | $61.29M | +41.5% | 58.1% | 0.6% | 0.6% |
| Dec 2020 | $43.31M | +76.1% | 55.7% | -4.9% | -5.1% |
| Dec 2019 | $24.60M | +16.0% | 62.8% | -15.0% | -12.8% |
| Dec 2018 | $21.21M | +256.2% | 57.6% | 0.8% | 1.1% |
| Dec 2017 | $5.95M | +37.2% | 100.0% | -35.8% | -35.3% |
| Dec 2016 | $4.34M | N/A | 100.0% | -36.4% | -35.5% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 54.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.43M | $92.13M | $71.52M | $62.45M | $61.29M | $43.31M | $24.60M | $21.21M | $5.95M | $4.34M |
| Cost of revenue | $35.83M | $32.75M | $28.62M | $23.48M | $25.65M | $19.21M | $9.16M | $9.00M | $0 | $0 |
| Gross profit | $73.59M | $59.38M | $42.90M | $38.97M | $35.64M | $24.11M | $15.44M | $12.21M | $5.95M | $4.34M |
| Operating income | $11.69M | -$13.71M | -$26.40M | -$12.29M | $361.10K | -$2.14M | -$3.69M | $180.13K | -$2.13M | -$1.58M |
| Net income | $5.13M | -$20.11M | -$17.57M | -$11.44M | $378.08K | -$2.21M | -$3.14M | $226.34K | -$2.10M | -$1.54M |
| EBITDA | $17.33M | -$8.39M | -$25.43M | -$10.27M | $2.34M | -$376.43K | -$3.15M | $496.63K | -$1.81M | -$1.35M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.61M | $20.50M | $19.84M | $32.24M | $26.07M | $29.20M | $21.93M | $32.32M | $21.31M | $18.81M | $19.69M | $28.37M |
| Gross profit | $16.25M | $15.69M | $14.93M | $24.10M | $17.52M | $18.64M | $13.34M | $22.02M | $13.45M | $11.70M | $12.20M | $17.84M |
| Operating income | $2.67M | -$88.00K | $396.00K | $8.57M | $2.07M | $3.21M | -$2.10M | $3.63M | -$8.56M | -$3.75M | -$5.03M | -$10.94M |
| Net income | $1.20M | -$703.00K | -$495.00K | $5.02M | $779.00K | $1.53M | -$2.20M | -$79.00K | -$9.12M | -$4.01M | -$6.90M | -$4.14M |
Balance Sheet
As of Dec 2025, total debt of $25.68M exceeded cash and equivalents by $2.31M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $176.92M | $171.17M | $183.37M | $134.65M | $140.99M | $60.33M | $56.64M | $25.05M | $9.76M | $11.48M |
| Current assets | $64.72M | $53.97M | $54.33M | $98.58M | $115.11M | $32.86M | $27.14M | $15.73M | $8.81M | $10.18M |
| Cash and equivalents | $23.36M | $13.38M | $13.85M | $18.21M | $84.68M | $10.52M | $18.85M | $8.91M | $5.12M | $7.03M |
| Total liabilities | $48.62M | $54.17M | $56.82M | $8.54M | $9.61M | $10.35M | $11.78M | $6.60M | $3.54M | $3.67M |
| Short-term debt | $4.25M | $2.00M | $2.00M | $0 | $90.98K | $123.22K | $115.43K | N/A | $1.18M | $2.50M |
| Long-term debt | $21.42M | $30.82M | $34.23M | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $128.29M | $117.00M | $126.55M | $126.11M | $131.38M | $49.97M | $44.86M | $18.46M | $6.22M | $7.81M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $162.09M | $164.32M | $167.26M | $176.92M | $170.32M | $169.26M | $167.77M | $171.17M | $165.20M | $172.88M | $176.37M | $183.37M |
| Total liabilities | $28.21M | $33.23M | $37.65M | $48.62M | $48.06M | $49.98M | $51.50M | $54.17M | $50.73M | $51.86M | $53.83M | $56.82M |
| Cash and equivalents | $22.32M | $24.10M | $20.17M | $23.36M | $19.52M | $16.59M | $16.57M | $13.38M | $16.13M | $14.96M | $15.18M | $13.85M |
| Shareholder equity | $133.88M | $131.08M | $129.61M | $128.29M | $122.26M | $119.28M | $116.27M | $117.00M | $114.47M | $121.02M | $122.54M | $126.55M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 99.7% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.71M | $4.89M | -$7.24M | $10.65M | $726.04K | -$6.31M | -$1.66M | $792.55K | -$1.48M | -$465.96K |
| Capital expenditures | $68.00K | $450.00K | $871.00K | $244.56K | $464.49K | $112.79K | $87.72K | $34.36K | $42.24K | $178.43K |
| Free cash flow | $18.65M | $4.44M | -$8.11M | $10.41M | $261.55K | -$6.42M | -$1.75M | $758.19K | -$1.52M | -$644.40K |
| Dividends paid | N/A | N/A | N/A | $226 | N/A | N/A | N/A | N/A | N/A | N/A |
| Share repurchases | N/A | N/A | $7.52M | $20.02M | $0 | N/A | N/A | N/A | $390.00K | $806.91K |
| Investing cash flow | $68.00K | -$450.00K | -$25.34M | -$58.18M | -$486.00K | -$124.72K | -$10.58M | -$5.69M | -$42.24K | -$349.54K |
| Financing cash flow | -$8.80M | -$4.91M | $28.22M | -$18.95M | $73.92M | -$1.90M | $22.18M | $8.69M | -$390.00K | -$357.42K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.74M | $8.61M | -$467.00K | $7.09M | $3.20M | $4.56M | $3.86M | $198.00K | $1.79M | $782.00K | $2.12M | -$6.26M |
| Capital expenditures | $12.00K | $35.00K | $21.00K | $206.00K | $10.00K | $44.00K | $84.00K | $120.00K | $92.00K | $85.00K | $153.00K | $772.00K |
| Free cash flow | $4.72M | $8.58M | -$488.00K | $6.88M | $3.19M | $4.52M | $3.78M | $78.00K | $1.70M | $697.00K | $1.97M | -$7.03M |
Frequently Asked Questions About OPRX
What is OPTIMIZERx's annual revenue?
OPTIMIZERx reported revenue of $109.43M for the fiscal year ended Dec 31, 2025.
How fast is OPTIMIZERx's revenue growing?
Revenue was up 18.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 20.6%.
Is OPTIMIZERx profitable?
Yes. OPTIMIZERx reported net income of $5.13M for the fiscal year ended Dec 31, 2025, with a net margin of 4.7%.
How much free cash flow does OPRX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $18.71M minus capital expenditures of $68.00K produced free cash flow of $18.65M.
How much debt does OPTIMIZERx have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $21.42M, short-term debt of $4.25M and cash and equivalents of $23.36M.
OPRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors